Stability, sterility, coagulation, and immunologic studies of salmon coagulation proteins with potential use for mammalian wound healing and cell engineering

Biomaterials

Volumn 27, Issue 34, 2006, Pages 5771-5779

  Laidmäe, Ivo ^a   McCormick, Margaret E ^b   Herod, Julia L ^c   Pastore, Jennifer J ^b   Salum, Tiit ^d   Sawyer, Evelyn S ^c   Janmey, Paul A ^b   Uibo, Raivo ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Sea Run Holdings Inc   (United States)

^d TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

Coagulation; Fibrin sealant; Fibrinogen; Salmon; Thrombin; Wound healing

Indexed keywords

FIBRIN SEALANT; FIBRINOGEN; SALMON; THROMBIN; WOUND HEALING;

COAGULATION; DISEASES; GAMMA RAYS; HEALTH RISKS; IMMUNOLOGY; SURGERY;

PROTEINS;

FIBRIN; FIBRIN GLUE; FIBRINOGEN; PROTEIN; SALMON COAGULATION PROTEIN; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CROSS REACTION; FEMALE; FLOW KINETICS; FREEZE DRYING; GAMMA IRRADIATION; IMMUNOLOGY; MALE; MAMMAL; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; RAT STRAIN; SALMON; TISSUE ENGINEERING; VIRUS LOAD; WOUND HEALING;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; FEMALE; FIBRIN TISSUE ADHESIVE; FIBRINOGEN; FIBRINOLYSIN; FREEZE DRYING; GAMMA RAYS; HUMANS; ISOELECTRIC FOCUSING; MALE; PLASMIN; RABBITS; RATS; RATS, WISTAR; SALMON; TISSUE ENGINEERING; WOUND HEALING;

ANIMALIA; MAMMALIA; ORYCTOLAGUS CUNICULUS; SALMO SALAR;

EID: 33747865478     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.07.035     Document Type: Article

References (22)

1. Clark R.A. Fibrin glue for wound repair: facts and fancy. Thromb Haemost 90 6 (2003) 1003-1006
2. Buchta C., Dettke M., Funovics P.T., Hirschl A.M., Macher M., Worel N., et al. Impact of manufacturing, irradiation and filtration steps to bacterial contamination of autologous fibrin sealant. Biologicals 32 3 (2004) 165-169
3. Buchta C., and Semple E. Blood bank produced fibrin sealant and bacterial contamination. Biologicals 33 3 (2005) 197-199
4. Feinberg E.B., and Funderburk R. Infectious disease risks of fibrin glue. Ophthalmic Surg 24 3 (1993) 206
5. Hino M., Ishiko O., Honda K.I., Yamane T., Ohta K., Takubo T., et al. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol 108 1 (2000) 194-195
6. Kawamura M., Sawafuji M., Watanabe M., Horinouchi H., and Kobayashi K. Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann Thorac Surg 73 4 (2002) 1098-1100
7. Zumberg M.S., Waples J.M., Kao K.J., and Lottenberg R. Management of a patient with a mechanical aortic valve and antibodies to both thrombin and factor V after repeat exposure to fibrin sealant. Am J Hematol 64 1 (2000) 59-63
8. Shirai T., Shimota H., Chida K., Sano S., Takeuchi Y., and Yasueda H. Anaphylaxis to aprotinin in fibrin sealant. Intern Med 44 10 (2005) 1088-1089
9. Beierlein W., Scheule A.M., Antoniadis G., Braun C., and Schosser R. An immediate, allergic skin reaction to aprotinin after reexposure to fibrin sealant. Transfusion 40 3 (2000) 302-305
10. Banninger H., Hardegger T., Tobler A., Barth A., Schupbach P., Reinhart W., et al. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol 85 3 (1993) 528-532
11. Seifert J., Klause N., Stobbe J., and Egbers H.J. Antibodies formed against fibrin glue components and their circulatory relevance. J Invest Surg 7 2 (1994) 167-171
12. Michaud S.E., Wang L.Z., Korde N., Bucki R., Randhawa P.K., Pastore J.J., et al. Purification of salmon thrombin and its potential as an alternative to mammalian thrombins in fibrin sealants. Thromb Res 107 5 (2002) 245-254
13. Wang L.Z., Gorlin J., Michaud S.E., Janmey P.A., Goddeau R.P., Kuuse R., et al. Purification of salmon clotting factors and their use as tissue sealants. Thromb Res 100 6 (2000) 537-548
14. Manseth E., Skjervold P.O., Fjaera S.O., Brosstad F.R., Bjornson S., and Flengsrud R. Purification and characterization of Atlantic salmon (Salmo salar) fibrinogen. Comp Biochem Physiol B Biochem Mol Biol 138 2 (2004) 169-174
15. Rothwell S.W., Reid T.J., Dorsey J., Flournoy W.S., Bodo M., Janmey P.A., et al. A salmon thrombin-fibrin bandage controls arterial bleeding in a swine aortotomy model. J Trauma 59 1 (2005) 143-149
16. Lannan C., Winton J., and Fryer J. Fish cell lines: establishment and characterization of nine cell lines from salmonids. In Vitro 20 (1984) 107-114
17. Dannevig B., Brudeseth B., Gjoen T., Rode M., Nergeland H., Evensen O., et al. Characterisation of a long-term cell line (SHK-1) developed from the head kidney of Atlantic salmon (Salmo salar L.). Fish Shell Immunol 7 (1997) 213-226
18. Reed L., and Muench H. A simple method for estimating 50% endpoints. Am J Hyg 27 (1932) 493-497
19. Janmey P.A., Lamb J.A., Ezzell R.M., Hvidt S., and Lind S.E. Effects of actin filaments on fibrin clot structure and lysis. Blood 80 4 (1992) 928-936
20. Shah J.V., and Janmey P.A. Strain hardening of fibrin gels and plasma clots. Rheol Acta 36 3 (1997) 262-268
21. Ortel T.L., Mercer M.C., Thames E.H., Moore K.D., and Lawson J.H. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 233 1 (2001) 88-96
22. Lawson J.H., Lynn K.A., Vanmatre R.M., Domzalski T., Klemp K.F., Ortel T.L., et al. Antihuman factor V antibodies after use of relatively pure bovine thrombin. Ann Thorac Surg 79 3 (2005) 1037-1038